Skip to main navigation

Overview
New & Events
- Press Releases
- Events & Presentations
Stock Information
Financial Information
- SEC Filings
Corporate Governance
Investor Resources

Press Releases

Press Releases

Year

Feb 25, 2021

Merck to Acquire Pandion Therapeutics

Feb 22, 2021

Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting

Feb 18, 2021

Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Jan 04, 2021

Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells

Print Page

RSS Feeds

Email Alerts

Investor Contact

Investor Contact

© 2021 Pandion Therapeutics. All rights reserved.